Answers are grounded in this paper and cite their sources.
Background/Objectives: Atopic dermatitis (AD) is associated with impaired quality of life and poor disease control. We aimed to describe patients attending their first specialist assessment in a tertiary AD unit and identify factors associated with poorer quality of life and poor perceived disease control. Methods: This single-centre cross-sectional study consecutively enrolled patients with AD and recorded clinical characteristics, treatment history, disease severity and patient-reported outcomes. Multivariable logistic regression assessed factors associated with Dermatology Life Quality Index (DLQI) > 10 and Atopic Dermatitis Control Tool (ADCT) ≥ 7. Complete-case analyses were supplemented by multiple imputation of missing covariates. Results: The study included 255 patients (mean age 37.4 years, 53.9% women). Flexural (33.3%) and diffuse (32.8%) phenotypes predominated, and 57.2% had at least one atopic comorbidity. Previous treatments included oral corticosteroids (44.0%), conventional systemic therapy (26.5%) and advanced therapy (6.9%). Among patients assessed, 25.0% had severe disease according to EASI and 31.9% according to SCORAD. A DLQI score > 10 was observed in 47/155 patients (30.3%) and an ADCT score ≥ 7 in 97/140 (69.3%). Greater itch intensity was associated with both outcomes, and sleep disturbance was associated with an ADCT score ≥ 7. The inverse association between a family history of atopy and a DLQI score > 10 showed a trend towards statistical significance (p = 0.058) after multiple imputation. Conclusions: Poor perceived control was common at the first specialist visit. The findings support assessing itch and sleep alongside clinical severity. The inverse association with a family history of atopy warrants further study.
No takes yet. Share an insight, caveat, or question.
Castro-Martín et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: